These findings confirmed that rs34637584 G/A and rs34637584 A/A (LRRK2 G2019S) were the primary genetic factors contributing to higher urinary BMP levels in the PD cohort compared to healthy controls. This evidence concerns the gene LRRK2 and Parkinson disease.